mk 287 has been researched along with l 652731 in 1 studies
Studies (mk 287) | Trials (mk 287) | Recent Studies (post-2010) (mk 287) | Studies (l 652731) | Trials (l 652731) | Recent Studies (post-2010) (l 652731) |
---|---|---|---|---|---|
6 | 0 | 0 | 7 | 0 | 0 |
Protein | Taxonomy | mk 287 (IC50) | l 652731 (IC50) |
---|---|---|---|
Platelet-activating factor receptor | Cavia porcellus (domestic guinea pig) | 0.022 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acton, JJ; Alberts, AW; Bach, TN; Ball, RG; Biftu, T; Bugianesi, RL; Chabala, JC; Girotra, NN; Parsons, WH; Ponpipom, MM | 1 |
1 other study(ies) available for mk 287 and l 652731
Article | Year |
---|---|
Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and
Topics: Administration, Oral; Animals; Furans; Guinea Pigs; Humans; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prodrugs; Rats; Solubility; Stereoisomerism; Structure-Activity Relationship; Sulfones | 1992 |